Results 101 to 110 of about 8,861 (229)
Predictive markers of hemorrhagic transformation in ischemic stroke
Ischemic stroke remains a major medical, social, and economic concern due to high disability rates and substantial treatment and rehabilitation costs. Reperfusion therapy (thrombolysis and thrombectomy) is one of the most effective therapeutic options ...
Olga V. Lyang +8 more
doaj +1 more source
Abstract Background Continuous subcutaneous apomorphine infusion (CSAI) is effective in Parkinson's disease but has not been evaluated in multiple system atrophy (MSA). Objective To assess the 6‐month efficacy and tolerability of CSAI in MSA patients. Methods French multicenter retrospective registry‐based analysis of CSAI use in MSA.
Simon Lamy +16 more
wiley +1 more source
Experimental digital atlas of blood supply zones of the internal carotid artery
Background: The compilation of a neuroanatomic atlas based on a large sample is essentially a fundamental research work, but compiling a digital atlas during the epoch of wide usage of radiodiagnostics methods in the clinical and experimental practice ...
Ilya L. Gubskiy +7 more
doaj +1 more source
Abstract Background Freezing of gait (FoG) belongs to most pressing unmet symptoms in the treatment of Parkinson's disease. Objectives To explore whether combined subthalamic and nigral (STN + SNr) deep brain stimulation improves FoG compared with optimized STN stimulation alone; to identify clinical variables associated with therapeutic response ...
Daniel Weiss +29 more
wiley +1 more source
Challenges of Pain in Parkinson's Disease: Results from the OCEAN Study
Abstract Background Pain is a common non‐motor symptom in Parkinson’s disease (PD) and is often associated to fluctuations. Objective The OpiCapone Effect on motor fluctuations and pAiN (OCEAN) study evaluated the effect of opicapone on fluctuation‐related pain when added to levodopa therapy in PD patients.
Kallol Ray Chaudhuri +13 more
wiley +1 more source
Developmental venous anomalies (DVA) are among the most common malformations, accounting for about 55% of all cerebral vascular anomalies. Most of them are asymptomatic, detected incidentally by brain magnetic resonance imaging and do not require ...
A. P. Demyanov +2 more
doaj +1 more source
Abstract Background Plasma phosphorylated‐tau at threonine‐217 (p‐tau217) and threonine‐181 (p‐tau181) are scalable, minimally invasive biomarkers of Alzheimer's disease (AD) pathology. In Parkinson's disease (PD), AD co‐pathology may contribute to its clinical heterogeneity.
Eleonora Fiorenzato +16 more
wiley +1 more source
ABSTRACT The issue of post‐trial responsibility is about what is owed to research participants after a clinical trial ends, who is responsible, and how long this responsibility must endure. Despite two decades of international guidance on this issue, research involving novel high‐risk interventions—such as implantable neurotechnologies—raises ...
Nathan Higgins +2 more
wiley +1 more source
Organizing the laboratory testing procedures in ischemic stroke patients
Background: Arranging the laboratory tests for the patients presenting with suspected ischemic stroke, represents an important task for medical organizations.
Olga V. Lyang +2 more
doaj +1 more source
TOP1MT rs2293925 is an enhancer‐active regulatory SNP that shapes mitochondrial R‐loop dynamics
This study shows how a common genetic variant of mitochondrial topoisomerase 1 (TOP1MT rs2293925) can influence mitochondrial gene regulation, DNA topology, and formation of noncanonical nucleic acid structures such as R‐loops. By linking this enhancer‐active variant to mitochondrial nucleic acid stress in cellular contexts relevant to amyotrophic ...
Dóra Varga +15 more
wiley +1 more source

